Medical/Pharmaceuticals
Royal Healthcare in Singapore provides NEC's "FonesVisuas Test" for Disease Risk Prediction
TOKYO, March 26, 2026 /PRNewswire/ -- NEC Corporation
2026-03-26 10:00
750
Hengrui Pharma Announces Strong 2025 Annual Results
SHANGHAI, March 25, 2026 /PRNewswire/ -- On March 25, 2026, Hengrui Pharma (600276.SH; 01276.HK) announced robust financial results for the full year 2025, fueled by its dual strategy of innovation and globalization. Revenue increased 13% year-on-year to RMB 31.63 billion, and net profit attribut...
2026-03-26 08:52
737
XtalPi Holdings Announces Full Year 2025 Annual Results
HONG KONG, March 25, 2026 /PRNewswire/ -- Financial Highlights: * Revenues for year 2025 were RMB802.6 million, representing a year-over-year increase of 201.2%. * Net profit for year 2025 reached reached RMB 134.6 million, while adjusted net profit amounted to RMB 258.2 million, making th...
2026-03-25 22:27
2403
Clarity signs a large-scale Manufacturing Supply Agreement for copper-64 with Theragenics
SYDNEY, March 25, 2026 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce the signing of a lar...
2026-03-25 21:01
1912
Heidi Receives Frost & Sullivan's 2026 North American Technology Innovation Leadership Recognition for Excellence in Artificial Intelligence Medical Scribe Innovation
The recognition highlights Heidi's leadership in clinical AI innovation, market
impact, and customer-centric technology design.
SAN ANTONIO, March 25, 2026 /PRNewswire/ -- Frost & Sullivan
2026-03-25 21:00
1823
Axtria Recognized as Frost & Sullivan's 2025 Global Company of the Year in Pharma Commercial Solutions
Honored for AI-Driven Innovation, Measurable Client Impact, and
Industry-Leading Commercialization Excellence
BERKELEY HEIGHTS, N.J., March 25, 2026 /PRNewswire/ -- Axtria Inc.
2026-03-25 20:33
1774
Waterdrop Q4 and FY2025 Financial Results: Q4 operating revenue rises 105.5% YoY, and declared a cash dividend
BEIJING, March 25, 2026 /PRNewswire/ -- Waterdrop Inc. (NYSE: WDH), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, today announced its unaudited financial results for the three and twelve months ended December 31, 2025 and a cash dividen...
2026-03-25 20:24
1972
Alteogen Enters into a License Agreement with Biogen for Development and Commercialization of Hybrozyme™-Based Subcutaneous Biologics
- Biogen gains rights to develop and commercialize subcutaneous (SC) formulations for two products utilizing ALT-B4 DAEJEON, South Korea, March 25, 2026 /PRNewswire/ -- Alteogen Inc. (KOSDAQ: 196170) announced today that it has entered into an exclusive license agreement with Biogen Inc. for the...
2026-03-25 20:00
1647
LakeShore Biopharma Announces Receipt of a Revised Preliminary Non-Binding Proposal to Acquire the Company
BEIJING, March 25, 2026 /PRNewswire/ -- LakeShore Biopharma Co., Ltd ("LakeShore Biopharma" or the "Company") (OTCPK: LSBCF; OTCPK: LSBWF), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics ...
2026-03-25 20:00
2142
Bioptimus Announces STELA: The World's Largest Clinically Linked Spatial Biology Atlas, alongside key partners 10x Genomics and Broad Clinical Labs
The global initiative aims to profile up to 100,000 patient specimens to scale M-Optimus, the world model of biology, representing a ~20x increase in scale over existing data available in the world today * The Launch of STELA: Bioptimus is establishing the largest clinically linked multimodal ...
2026-03-25 19:00
1506
ENNOVI Secures German Patent Approval for Adhesive-Free Lamination in Battery Cell Contacting Systems
Offering a new, validated CCS design pathway, reducing uncertainty for cautious
battery engineers
NECKARSULM, Germany, March 25, 2026 /PRNewswire/ -- ENNOVI
2026-03-25 19:00
1559
WuXi Biologics Reports Record 2025 Annual Results, Operational Excellence Driven by Digital-Native Architecture
SHANGHAI, March 25, 2026 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), has released its annual results for 2025, demonstrating record growth and a transformative leap in operational sophistication. Th...
2026-03-25 18:22
1905
HanchorBio Advances Toward TWSE Innovation Board Listing to Accelerate Global Clinical Development, Platform Expansion, and International Partnering
Listing milestone positions HanchorBio to strengthen institutional visibility, advance itsFBDB™ platform, and expand a growing pipeline spanning oncology and broader immune-mediated diseases TAIPEI, SHANGHAI and SAN FRANCISCO, March 25, 2026 /PRNewswire/ -- HanchorBio, Inc. (TPEx: 7827), a globa...
2026-03-25 18:00
1557
VERIGRAFT Advances First Potential Curative Treatment for CVI into Pivotal Phase II/III Trial
* Pivotal Phase II/III clinical trial underway, aiming for US and European market approval in 2028 * A 'truly transformative' regenerative medicine targeting a multi-million patient population with no existing curative treatment * Fully biological transplant eliminates need for immunosuppres...
2026-03-25 17:11
1499
Why Chronic Eczema Can Last for Decades, and What a Recent Case Is Revealing
Tangs Clinical TCM Highlights Why Chronic Eczema Can Persist for Decades SINGAPORE, March 25, 2026 /PRNewswire/ -- A recent patient case managed by Tangs Clinical TCM has shed light on why chronic eczema can last for years, and how long-term, structured management may influence symptom patterns o...
2026-03-25 15:40
1263
BrightGene Announces Positive Topline Phase 1 Results of Oral BGM0504 in Obesity in China and the United States
BGM0504 shown to be generally well tolerated Overall safety, pk, and efficacy profile supports once-daily oral dosing SUZHOU, China, March 25, 2026 /PRNewswire/ -- BrightGene Bio-Medical Technology Co., Ltd. (SSE: 688166, "BrightGene" or "the Company") today announced positive topline results f...
2026-03-25 14:32
1607
Fujitsu and The University of Osaka develop new technologies for chemical material energy calculations on early-FTQC quantum computers
Contributing to the early application of quantum computers in drug discovery and new material development TOKYO, March 25, 2026 /PRNewswire/ -- Fujitsu Limited and the Center for Quantum Information and Quantum Biology at The University of Osaka today announced the development of a new technolo...
2026-03-25 13:29
1790
Open-Sourcing to Empower, AI to Lead Medicine: "SurgMotion", the Best-in-class Surgical Video Foundation Model, Officially Launched
HONG KONG, March 25, 2026 /PRNewswire/ -- On 24 March, the Centre for Artificial Intelligence and Robotics (CAIR), Hong Kong Institute of Science & Innovation (HKISI), and the Chinese Academy of Sciences unveiled "SurgMotion" — a surgical video foundation model — at the Hong Kong Science and Tech...
2026-03-25 11:00
2177
Akeso Advances "IO 2.0 + ADC 2.0" Strategy with Phase II Initiation of Novel ADCs Combined with Ivonescimab and Cadonilimab
HONG KONG, March 24, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced today that it has received clearance from the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) to initiate Phase II clinical trials for AK146D1, a first...
2026-03-25 10:40
2096
From SCAN to SPARK: Galaxy Brain Scientific Enables a New Paradigm in Non-invasive, Personalized Precision Treatment for Parkinson's Disease
BEIJING, March 24, 2026 /PRNewswire/ -- A research team led by Prof. Hesheng Liu, founder and Chief Scientific Officer of Galaxy Brain Scientific Inc., has published a study in Nature Neuroscience demonstrating that Deep Brain Stimulation (DBS) achieves therapeutic efficacy in Parkinson's disease...
2026-03-25 10:34
1850
Week's Top Stories
Most Reposted
Visa Working Capital Index: Asia Pacific CFOs Call for Flexible, Digital Finance Solutions
[Picked up by 308 media titles]
2026-03-24 14:00HOY Unveils a Powerhouse Line-up of Talent for its Bold New Chapter
[Picked up by 306 media titles]
2026-03-20 09:36
MetaOptics progresses on its strategic growth and leadership transition initiatives
[Picked up by 283 media titles]
2026-03-20 08:15ART CENTRAL COMMENCES DISCOVERY-LED ELEVENTH EDITION
[Picked up by 277 media titles]
2026-03-25 16:51
Allianz Partners Australia's 2025 State of Student Healthcare Report Unpacks the Complex Realities of International Students
[Picked up by 275 media titles]
2026-03-19 09:00Most Read
Everbright Environment Announces 2025 Annual Results
2026-03-20 23:14
7695
Ten Pao Group Announces 2025 Annual Results
2026-03-20 23:35
7492
FiEE, Inc. Announces Fourth Quarter and Full-Year 2025 Financial Results
2026-03-21 04:05
7472
U Power Limited Announces Closing of $6.0 Million Public Offering
2026-03-21 02:40
7012